INTERNATIONAL MONEY EXPRESS (IMXI) Fundamental Analysis & Valuation

NASDAQ:IMXI • US46005L1017

15.8 USD
0 (0%)
At close: Mar 10, 2026
15.8 USD
0 (0%)
After Hours: 3/10/2026, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This IMXI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, IMXI scores 5 out of 10 in our fundamental rating. IMXI was compared to 98 industry peers in the Financial Services industry. While IMXI has a great profitability rating, there are some minor concerns on its financial health. IMXI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. IMXI Profitability Analysis

1.1 Basic Checks

  • IMXI had positive earnings in the past year.
  • IMXI had a positive operating cash flow in the past year.
  • IMXI had positive earnings in each of the past 5 years.
  • IMXI had a positive operating cash flow in 4 of the past 5 years.
IMXI Yearly Net Income VS EBIT VS OCF VS FCFIMXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 8.17%, IMXI belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • IMXI has a better Return On Equity (26.14%) than 90.82% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 17.29%, IMXI belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
  • IMXI had an Average Return On Invested Capital over the past 3 years of 20.03%. This is significantly above the industry average of 8.33%.
Industry RankSector Rank
ROA 8.17%
ROE 26.14%
ROIC 17.29%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
IMXI Yearly ROA, ROE, ROICIMXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

  • IMXI has a Profit Margin of 6.26%. This is comparable to the rest of the industry: IMXI outperforms 45.92% of its industry peers.
  • In the last couple of years the Profit Margin of IMXI has grown nicely.
  • With a Operating Margin value of 12.79%, IMXI perfoms like the industry average, outperforming 53.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IMXI has grown nicely.
Industry RankSector Rank
OM 12.79%
PM (TTM) 6.26%
GM N/A
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
IMXI Yearly Profit, Operating, Gross MarginsIMXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. IMXI Health Analysis

2.1 Basic Checks

  • IMXI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • IMXI has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IMXI has been reduced compared to 5 years ago.
  • The debt/assets ratio for IMXI is higher compared to a year ago.
IMXI Yearly Shares OutstandingIMXI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IMXI Yearly Total Debt VS Total AssetsIMXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • IMXI has an Altman-Z score of 3.93. This indicates that IMXI is financially healthy and has little risk of bankruptcy at the moment.
  • IMXI has a better Altman-Z score (3.93) than 85.71% of its industry peers.
  • The Debt to FCF ratio of IMXI is 11.59, which is on the high side as it means it would take IMXI, 11.59 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 11.59, IMXI is in line with its industry, outperforming 43.88% of the companies in the same industry.
  • A Debt/Equity ratio of 1.06 is on the high side and indicates that IMXI has dependencies on debt financing.
  • IMXI has a Debt to Equity ratio of 1.06. This is comparable to the rest of the industry: IMXI outperforms 41.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 11.59
Altman-Z 3.93
ROIC/WACC2.19
WACC7.89%
IMXI Yearly LT Debt VS Equity VS FCFIMXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • IMXI has a Current Ratio of 2.03. This indicates that IMXI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.03, IMXI is doing good in the industry, outperforming 76.53% of the companies in the same industry.
  • A Quick Ratio of 2.03 indicates that IMXI has no problem at all paying its short term obligations.
  • IMXI has a Quick ratio of 2.03. This is in the better half of the industry: IMXI outperforms 76.53% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03
IMXI Yearly Current Assets VS Current LiabilitesIMXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IMXI Growth Analysis

3.1 Past

  • IMXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.81%.
  • The Earnings Per Share has been growing by 26.76% on average over the past years. This is a very strong growth
  • IMXI shows a decrease in Revenue. In the last year, the revenue decreased by -6.09%.
  • IMXI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.56% yearly.
EPS 1Y (TTM)-15.81%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-37.7%
Revenue 1Y (TTM)-6.09%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-9.9%

3.2 Future

  • Based on estimates for the next years, IMXI will show a decrease in Earnings Per Share. The EPS will decrease by -0.20% on average per year.
  • The Revenue is expected to decrease by -1.03% on average over the next years.
EPS Next Y-15.63%
EPS Next 2Y-5.78%
EPS Next 3Y-0.2%
EPS Next 5YN/A
Revenue Next Year-5.6%
Revenue Next 2Y-2.45%
Revenue Next 3Y-1.03%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMXI Yearly Revenue VS EstimatesIMXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
IMXI Yearly EPS VS EstimatesIMXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. IMXI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.73, the valuation of IMXI can be described as reasonable.
  • 65.31% of the companies in the same industry are more expensive than IMXI, based on the Price/Earnings ratio.
  • IMXI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.25.
  • A Price/Forward Earnings ratio of 8.24 indicates a reasonable valuation of IMXI.
  • Based on the Price/Forward Earnings ratio, IMXI is valued a bit cheaper than the industry average as 65.31% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.39, IMXI is valued rather cheaply.
Industry RankSector Rank
PE 8.73
Fwd PE 8.24
IMXI Price Earnings VS Forward Price EarningsIMXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMXI is valued cheaper than 91.84% of the companies in the same industry.
  • IMXI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.46
EV/EBITDA 4.95
IMXI Per share dataIMXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • IMXI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-5.78%
EPS Next 3Y-0.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMXI Dividend Analysis

5.1 Amount

  • No dividends for IMXI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMXI Fundamentals: All Metrics, Ratios and Statistics

INTERNATIONAL MONEY EXPRESS

NASDAQ:IMXI (3/10/2026, 8:00:03 PM)

After market: 15.8 0 (0%)

15.8

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners88.89%
Inst Owner Change-10.31%
Ins Owners6.87%
Ins Owner Change5.42%
Market Cap469.58M
Revenue(TTM)625.12M
Net Income(TTM)39.12M
Analysts51.67
Price Target16.32 (3.29%)
Short Float %3.07%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.32%
Min EPS beat(2)-30.31%
Max EPS beat(2)-0.33%
EPS beat(4)0
Avg EPS beat(4)-13.57%
Min EPS beat(4)-30.31%
Max EPS beat(4)-0.33%
EPS beat(8)3
Avg EPS beat(8)-5.77%
EPS beat(12)6
Avg EPS beat(12)-3.64%
EPS beat(16)10
Avg EPS beat(16)0.1%
Revenue beat(2)0
Avg Revenue beat(2)-6.03%
Min Revenue beat(2)-8.09%
Max Revenue beat(2)-3.97%
Revenue beat(4)0
Avg Revenue beat(4)-5.13%
Min Revenue beat(4)-8.09%
Max Revenue beat(4)-3.97%
Revenue beat(8)0
Avg Revenue beat(8)-4.28%
Revenue beat(12)0
Avg Revenue beat(12)-3.38%
Revenue beat(16)1
Avg Revenue beat(16)-2.73%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.67%
EPS NQ rev (3m)-3.67%
EPS NY rev (1m)-2.72%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE 8.73
Fwd PE 8.24
P/S 0.75
P/FCF 34.46
P/OCF 9.86
P/B 3.14
P/tB 6.91
EV/EBITDA 4.95
EPS(TTM)1.81
EY11.46%
EPS(NY)1.92
Fwd EY12.14%
FCF(TTM)0.46
FCFY2.9%
OCF(TTM)1.6
OCFY10.14%
SpS21.03
BVpS5.04
TBVpS2.29
PEG (NY)N/A
PEG (5Y)0.33
Graham Number14.32
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 26.14%
ROCE 24.59%
ROIC 17.29%
ROICexc 32.38%
ROICexgc 61.19%
OM 12.79%
PM (TTM) 6.26%
GM N/A
FCFM 2.18%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
ROICexc(3y)43.96%
ROICexc(5y)44.35%
ROICexgc(3y)95.79%
ROICexgc(5y)98.86%
ROCE(3y)28.49%
ROCE(5y)29.26%
ROICexgc growth 3Y-16.32%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.68%
ROICexc growth 5Y-2.6%
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 11.59
Debt/EBITDA 1.64
Cap/Depr 210.43%
Cap/Sales 5.44%
Interest Coverage 7.62
Cash Conversion 49.55%
Profit Quality 34.83%
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z 3.93
F-Score5
WACC7.89%
ROIC/WACC2.19
Cap/Depr(3y)181.12%
Cap/Depr(5y)138.87%
Cap/Sales(3y)3.56%
Cap/Sales(5y)2.84%
Profit Quality(3y)80.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.81%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-37.7%
EPS Next Y-15.63%
EPS Next 2Y-5.78%
EPS Next 3Y-0.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.09%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-9.9%
Revenue Next Year-5.6%
Revenue Next 2Y-2.45%
Revenue Next 3Y-1.03%
Revenue Next 5YN/A
EBIT growth 1Y-20.79%
EBIT growth 3Y13.31%
EBIT growth 5Y22.35%
EBIT Next Year6.41%
EBIT Next 3Y4.19%
EBIT Next 5YN/A
FCF growth 1Y-85.91%
FCF growth 3Y-46.37%
FCF growth 5Y-25.68%
OCF growth 1Y-55.68%
OCF growth 3Y-12.08%
OCF growth 5Y0.21%

INTERNATIONAL MONEY EXPRESS / IMXI FAQ

What is the fundamental rating for IMXI stock?

ChartMill assigns a fundamental rating of 5 / 10 to IMXI.


What is the valuation status of INTERNATIONAL MONEY EXPRESS (IMXI) stock?

ChartMill assigns a valuation rating of 6 / 10 to INTERNATIONAL MONEY EXPRESS (IMXI). This can be considered as Fairly Valued.


How profitable is INTERNATIONAL MONEY EXPRESS (IMXI) stock?

INTERNATIONAL MONEY EXPRESS (IMXI) has a profitability rating of 7 / 10.


Can you provide the financial health for IMXI stock?

The financial health rating of INTERNATIONAL MONEY EXPRESS (IMXI) is 6 / 10.


Is the dividend of INTERNATIONAL MONEY EXPRESS sustainable?

The dividend rating of INTERNATIONAL MONEY EXPRESS (IMXI) is 0 / 10 and the dividend payout ratio is 0%.